OMER
Omeros Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +7.7% ·
aandelenstroom +4.0% ·
netto nieuwe posities +7.1%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | -1 | 26.88M | $255.76M | +8 | −9 |
| Q1 2026 | 78 | +7 | 23.56M | $249.21M | +9 | −2 |
| Q4 2025 | 71 | -2 | 30.19M | $466.97M | — | −2 |
| Q3 2025 | 17 | 0 | 17.59M | $72.13M | — | — |
| Q2 2025 | 14 | +1 | 14.04M | $42.12M | +1 | — |
| Q1 2025 | 10 | +1 | 6.15M | $50.54M | +1 | — |
| Q4 2024 | 9 | 0 | 4.83M | $47.77M | +1 | −1 |
| Q3 2024 | 8 | +1 | 3.34M | $13.26M | +1 | — |
| Q2 2024 | 7 | — | 3.21M | $13.02M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.05M | — | $12.15M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 3.28M | — | $9.85M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 3.28M | — | $9.85M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 3.28M | — | $9.85M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.65M | -15.0% | $4.94M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 1.65M | -15.0% | $4.94M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 1.37M | +0.1% | $4.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 1.37M | +0.1% | $4.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passief) | 1.20M | -11.5% | $3.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 741.38K | +15.1% | $2.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 741.38K | +15.1% | $2.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 670.22K | +534.4% | $2.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 382.70K | Nieuw | $1.15M | 0.0% | New | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 269.42K | -14.5% | $808,263 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 163.41K | +20.1% | $490,239 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Wellington Management ✦ | 163.41K | +20.1% | $490,239 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Wellington Management ✦ | 163.41K | +20.1% | $490,239 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 157.71K | -8.8% | $473,130 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 76.79K | +1.7% | $231,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 13.86K | -60.0% | $41,586 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 13.86K | -60.0% | $41,586 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 11.64K | — | $34,920 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $1.15M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 4.17M aandelen, $8.90M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 906 aand · $17,305
Officer · 10.00K aand · $189,500
Director · 15.00K aand · $276,772
Officer · 5.00K aand · $84,750
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie